(Q39794757)

14 September 2017

title

Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer (English)

1 reference

14 September 2017

Xue-lian Du

1

1 reference

14 September 2017

Tao Jiang

2

1 reference

14 September 2017

Xiu-gui Sheng

3

1 reference

14 September 2017

Rong Gao

4

1 reference

14 September 2017

Qing-shui Li

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

23 September 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

115

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

371-376

1 reference

Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin and colon cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Transformed mammalian cells secrete specific proteins and phosphoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin distribution in the canine skeleton during growth and structural maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Inhibition of osteopontin would suppress angiogenesis in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.029

10.1016/J.YGYNO.2009.08.029

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference